| Literature DB >> 17550583 |
Daniel Tetaert1, Maud Pierre, Dominique Demeyer, Marie-Odile Husson, Laurent Béghin, Claude Galabert, Frédéric Gottrand, Christopher Beermann, Benoit Guery, Jean-Luc Desseyn.
Abstract
BACKGROUND: Mucin hypersecretion and mucus plugging in the airways are characteristic features of chronic respiratory diseases like cystic fibrosis (CF) and contribute to morbidity and mortality. In CF, Pseudomonas aeruginosa superinfections in the lung exacerbate inflammation and alter mucus properties. There is increasing evidence that n-3 polyunsaturated fatty acids (PUFAs) exhibit anti-inflammatory properties in many inflammatory diseases while n-6 PUFA arachidonic acid (AA) favors inflammatory mediators such as eicosanoids prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) that may enhance inflammatory reactions. This suggests that n-3 PUFAs may have a protective effect against mucus over-production in airway diseases. Therefore, we hypothesized that n-3 PUFAs may downregulate mucins expression.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17550583 PMCID: PMC1899493 DOI: 10.1186/1465-9921-8-39
Source DB: PubMed Journal: Respir Res ISSN: 1465-9921
Composition in fatty acids of the three diets (mg/100 mg of FA)
| Group | ω3 | ω6 | control | |
| Fatty acid | ||||
| S-FA | 11.7 | 25.9 | 31.3 | |
| MUFA | 52.0 | 42.0 | 49.9 | |
| ALA | 18:3n-3 | 3.1 | 3.2 | |
| STA | 18:4n-3 | < 0.1 | < 0.1 | |
| EPA | 20:5n-3 | 12.7 | < 0.1 | < 0.1 |
| DHA | 22:6n-3 | 0.1 | < 0.1 | |
| LA | 18:2n-6 | 14.2 | 12.8 | 14.5 |
| GLA | 18:3n-6 | < 0.1 | 1.0 | < 0.1 |
| AA | 20:4n-6 | 0.7 | 0.1 | |
abbreviations : FA, fatty acids; S-FA, total saturated FA; MUFA, mono-unsaturated FA; ALA, alpha-linolenic acid; STA, stearidonic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; LA, linoleic acid; GLA, gamma-linolenic acid; AA, arachidonic acid
Primer and probe sequences for murine mucins
| Mucin | Sequence (5'-3') | Product length | |
| Muc4 | FW | GTCCACTTCTTCCCCATCTC | |
| RV | GTAGCCTTTGTAGCCATCACAT | ||
| PB | CCAGGACCAGATGGCTCTGAACCT | 102 bp | |
| Muc5b | FW | GCACGTAAATGCGACTGTCT | |
| RV | ATGGACCTTGCTCTCCTGAC | ||
| PB | TATCCAAGTACTCCATGGAGGCCC | 133 bp | |
| Muc5ac | FW | TCCCTTACCTAACCAGCAGAA | |
| RV | GGGAGTACATGGAGATGCTGT | ||
| PB | GAGGGCCCAGTGAGCATCTCCTACT | 118 bp |
FW, forward primer; RV, reverse primer; PB, TaqMan probe dual-labeled with 5'FAM and 3'TAMRA.
Figure 1Graphical representation of linear regression analyses to validate the quantitative real-time PCR (qPCR) assay. Dilutions of plasmid cDNA were amplified by qPCR in duplicate reactions, and standard curves were created by plotting the cycle threshold (Ct) values versus DNA quantity (Log quantity) in ng for 18s, Muc4, Muc5ac and Muc5b.
Figure 2Gene expression analysis in lung by absolute qPCR of mouse Muc4, Muc5ac and Muc5b transcripts normalized with the 18s. Five healthy mice fed with the control diet for 5 weeks were used in each group. Ratios between the absolute amounts of the three Muc copy numbers and the 18s copy number is given in Log10 (Muc/18s)+11 due to the high difference between the Muc4 level expression and the two other Mucs gene expression levels.
Figure 3Effect of the diet on the mouse Muc4, Muc5b and Muc5ac gene expressions of mice inoculated with sterile agarose beads. Values represent the Log10 copy number of each Muc transcript normalized with the 18s (log(Muc/18s))+11. Exact P-values were calculated to compare the effect between days for a given diet (ω3: n-3 PUFA treated group; C: control diet group; ω6: n-6 PUFA treated group) or between diets for a given day. Significant P-values are given in 2 × 2 tables.
Figure 4Suppressive effect of an n-3 PUFAs enriched diet on the Muc gene expression of mice infected with P. aeruginosa. Values represent 6+log [(Muc of infected lung/18s of infected lung)/median(Muc of sterile beads/18s of sterile beads)]. Exact P-values were calculated to compare the effect between days for a given diet (ω3: n-3 PUFA treated group; C: control diet group; ω6: n-6 PUFA treated group) or between diets for a given day. Significant P-values are given in 2 × 2 tables.